Xiaodong Jiao

Department of Medical Oncology, Changzheng Hospital

Research Area

Biography

Xiaodong Jiao has not added Biography.
If you are Xiaodong Jiao and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 3	2023

Other Publications

Article	Year
Effect of sunitinib combined with ionizing radiation on endothelial cells. Journal of radiation research\| PubMed ID: 21187670	2011
Pemetrexed versus docetaxel in second line non-small-cell lung cancer: results and subsets analyses of a multi-center, randomized, exploratory trial in Chinese patients. Pulmonary pharmacology & therapeutics\| PubMed ID: 22766314	2012
[Clinical observation of prophylactic lactulose for prevention of oral morphine-induced constipation]. Zhonghua yi xue za zhi\| PubMed ID: 23328286	2012
Metformin potentiates rapamycin and cisplatin in gastric cancer in mice. Oncotarget\| PubMed ID: 25909163	2015
Paralytic ileus due to a novel anticancer drug, nab-paclitaxel: A case report. Molecular and clinical oncology\| PubMed ID: 27123288	2016
[Advances in Patient Derived Tumor Xenograft (PDTX) Model from Lung Cancer]. Zhongguo fei ai za zhi = Chinese journal of lung cancer\| PubMed ID: 29061220	2017
Increased SNAT1 is a marker of human osteosarcoma and potential therapeutic target. Oncotarget\| PubMed ID: 29108276	2017
Primary pulmonary leiomyosarcoma: A population-based study. Lung cancer (Amsterdam, Netherlands)\| PubMed ID: 29413053	2018
Rapid symptomatic relief of HER2-positive gastric cancer leptomeningeal carcinomatosis with lapatinib, trastuzumab and capecitabine: a case report. BMC cancer\| PubMed ID: 29463236	2018
Adenosquamous carcinoma of the bile duct: a population-based study. Cancer management and research\| PubMed ID: 29563834	2018
ADAM-17 is a poor prognostic indicator for patients with hilar cholangiocarcinoma and is regulated by FoxM1. BMC cancer\| PubMed ID: 29776401	2018
Tumor mutation burden to tumor burden ratio and prediction of clinical benefit of anti-PD-1/PD-L1 immunotherapy. Medical hypotheses\| PubMed ID: 29857892	2018
The prognostic value of TP53 and its correlation with EGFR mutation in advanced non-small cell lung cancer, an analysis based on cBioPortal data base. Lung cancer (Amsterdam, Netherlands)\| PubMed ID: 30089598	2018
The effectiveness of afatinib and osimertinib in a Chinese patient with advanced lung adenocarcinoma harboring a rare triple EGFR mutation (R670W/H835L/L833V): a case report and literature r... OncoTargets and therapy\| PubMed ID: 30127622	2018
Clinical, pathological and treatment factors associated with the survival of patients with primary pulmonary salivary gland-type tumors. Lung cancer (Amsterdam, Netherlands)\| PubMed ID: 30527184	2018
Basket Trials for Intractable Cancer. Frontiers in oncology\| PubMed ID: 31032221	2019
The RNA-Binding Protein HuR Confers Oxaliplatin Resistance of Colorectal Cancer By Upregulating CDC6. Molecular cancer therapeutics\| PubMed ID: 31064870	2019
Identification of a Novel EML4-ALK, BCL11A-ALK Double-Fusion Variant in Lung Adenocarcinoma Using Next-Generation Sequencing and Response to Crizotinib. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer\| PubMed ID: 31122560	2019
MTSS1 inhibits metastatic potential and induces G2/M phase cell cycle arrest in gastric cancer. OncoTargets and therapy\| PubMed ID: 31303767	2019
The prognostic value of tumor mutation burden in -mutant advanced lung adenocarcinoma, an analysis based on cBioPortal data base. Journal of thoracic disease\| PubMed ID: 31903239	2019
The effect of liver metastasis on efficacy of immunotherapy plus chemotherapy in advanced lung cancer. Critical reviews in oncology/hematology\| PubMed ID: 32065969	2020
Response to Pyrotinib in a Chinese Patient with Bone-Metastatic Scrotal Paget's Disease Harboring Triple Uncommon HER2 Mutation: A Case Report. OncoTargets and therapy\| PubMed ID: 32753879	2020
Tumor mutation burden in Chinese cancer patients and the underlying driving pathways of high tumor mutation burden across different cancer types. Annals of translational medicine\| PubMed ID: 32793704	2020
Metastatic Low-Grade Sarcoma with CARS-ALK Fusion Dramatically Responded to Multiple ALK Tyrosine Kinase Inhibitors: A Case Report with Comprehensive Genomic Analysis. The oncologist\| PubMed ID: 32997436	2021
Comparing Immunotherapies in Combination With Chemotherapy for Previously Untreated Advanced Nonsquamous NSCLC. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer\| PubMed ID: 33246598	2020
Primary squamous cell carcinoma of pancreas: a population-based study. Gland surgery\| PubMed ID: 33842247	2021
HER2 Splice Site Mutation c.1899-1G>A as the Potential Acquired Resistance to Trastuzumab in a Patient with HER2-Positive Gastric Adenocarcinoma. The oncologist\| PubMed ID: 33896090	2021
Clinical Responses to Crizotinib, Alectinib, and Lorlatinib in a Metastatic Colorectal Carcinoma Patient With ALK Gene Rearrangement: A Case Report. JCO precision oncology\| PubMed ID: 34036227	2021
Effects of concomitant proton pump inhibitor use on immune checkpoint inhibitor efficacy among patients with advanced cancer. Oncoimmunology\| PubMed ID: 34350061	2021
Serum tumor markers for the prediction of concordance between genomic profiles from liquid and tissue biopsy in patients with advanced lung adenocarcinoma. Translational lung cancer research\| PubMed ID: 34430361	2021
Blood small extracellular vesicles derived miRNAs to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis. Clinical and translational medicine\| PubMed ID: 34586739	2021
Cetuximab and vemurafenib plus FOLFIRI (5-fluorouracil/leucovorin/irinotecan) for BRAF V600E-mutated advanced colorectal cancer (IMPROVEMENT): An open-label, single-arm, phase II trial. European journal of cancer (Oxford, England : 1990)\| PubMed ID: 35074651	2022
Palbociclib for the Treatment of Metastatic Nasopharyngeal Carcinoma With CDK4 Amplification: A Case Report. JCO precision oncology\| PubMed ID: 35100720	2019
Effect of smoking habits on the efficacy of EGFR-TKI plus anti-angiogenic agent in advanced EGFR-mutant NSCLC. Lung cancer (Amsterdam, Netherlands)\| PubMed ID: 35728482	2022
Low-dose anti-VEGFR2 therapy promotes anti-tumor immunity in lung adenocarcinoma by down-regulating the expression of layilin on tumor-infiltrating CD8T cells. Cellular oncology (Dordrecht)\| PubMed ID: 36260222	2022
Double spiral chip-embedded micro-trapezoid filters (SMT filters) for the sensitive isolation of CTCs of prostate cancer by spectral detection. Nanoscale advances\| PubMed ID: 36540122	2022
Prognostic value of tumor mutation burden in patients with advanced gastric cancer receiving first-line chemotherapy. Frontiers in oncology\| PubMed ID: 36686739	2022
Targeted therapy for intractable cancer on the basis of molecular profiles: An open-label, phase II basket trial (Long March Pathway). Frontiers in oncology\| PubMed ID: 36910668	2023
Pan-cancer efficacy and safety of anlotinib plus PD-1 inhibitor in refractory solid tumor: A single-arm, open-label, phase II trial. International journal of cancer\| PubMed ID: 37155342	2023
Expert consensus on the diagnosis and treatment of RET gene fusion non-small cell lung cancer in China. Thoracic cancer\| PubMed ID: 37718634	2023